EXACT Sciences Corp. of Marlborough has regained Nasdaq compliance.
In August, after the company was unable to maintain a $50 million market value, the stock market threatened to delist it. Instead, in November, Nasdaq moved the stock from its Global Market to its Capital Market on a temporary basis, even though it did not meet the Capital Market’s listing requirements at that time.
Now, EXACT says it is in compliance with the Capital Market requirements and will continue to trade there.
EXACT Sciences develops screening technologies for the detection of cancer.
